Interestingly, 16 of 21 cancer entities analysed presented significant higher PIF1 expression level and confirmed previous data focusing on cervical cancer (53), non-small cell lung cancer (54) and pancreatic cancer (55). This evidence concerns the gene PIF1 and non-small cell lung carcinoma.